Ensoli; Barbara

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ensoli; Barbara.The latest application filed is for "use of replication deficient hsv-1 as a vaccine vector for the deli vary of hiv-1 tat antigen".

Company Profile

1.11.12

Ensoli; Barbara - Rome IT
ENSOLI; Barbara - Roma IT
Ensoli; Barbara - I-Roma IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Tat complexes, and vaccines comprising them Grant 9,969,780 - Ensoli May 15, 2	2018-05-15
Replication-competent adenoviral vectors Grant 9,732,359 - Peng , et al. August 15, 2	2017-08-15
Method of improving immune function in HIV-infected subjects on HAART by administering HIV-1 TAT Grant 9,630,995 - Ensoli April 25, 2	2017-04-25
Replication-competent adenoviral vectors Grant 9,216,214 - Peng , et al. December 22, 2	2015-12-22
Use Of Replication Deficient Hsv-1 As A Vaccine Vector For The Deli Vary Of Hiv-1 Tat Antigen App 20150359878 - MARCONI; Peggy ; et al.	2015-12-17
Replication-competent Adenoviral Vectors App 20150231229 - PENG; Bo ; et al.	2015-08-20
Replication-competent adenoviral vectors Grant 8,926,987 - Peng , et al. January 6, 2	2015-01-06
Immune Therapy App 20130058973 - Ensoli; Barbara	2013-03-07
HIV-1 Tat, or derivatives thereof for prophylactic and therapeutic vaccination Grant 8,197,820 - Ensoli June 12, 2	2012-06-12
Process For The Production Of Biologically Active Hiv-1 Tat Protein App 20110319593 - Ensoli; Barbara ; et al.	2011-12-29
Compositions of antigens bound to HIV-1 Tat, fragments or derivatives thereof Grant 7,811,573 - Ensoli October 12, 2	2010-10-12
HIV-1 Tat compositions Grant 7,744,896 - Ensoli June 29, 2	2010-06-29
Hiv-1 Tat, Or Derivatives Thereof For Prophylactic And Therapeutic Vaccination App 20100015087 - ENSOLI; BARBARA	2010-01-21
Vaccines containing the hiv tat protein as an adjuvant for the enhancement of cytotoxic t-cell responses App 20090252754 - Caputo; Antonella ; et al.	2009-10-08
Use of Microparticles for Antigen Delivery App 20070275071 - Ensoli; Barbara ; et al.	2007-11-29
Nanoparticles for delivery of a pharmacologically active agent App 20060280798 - Ensoli; Barbara	2006-12-14
Replication-competent adenoviral vectors App 20060115456 - Peng; Bo ; et al.	2006-06-01
Use of inhibitors of the protease of the human immunodeficiency virus (hiv) to block cell migration and/or invasion, tissue infiltration and oedema for the therary of diseases associated therewith App 20060088545 - Ensoli; Barbara	2006-04-27
Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases App 20050036985 - Ensoli, Barbara	2005-02-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.